← Leaderboards
Elizabeth R Volkmann
University Of California Los Angeles
$1,603,888
Attributed
$1,603,888
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $693.6K · FY2020–25$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,603,888 · 2
By mechanism
K23$910,330 · 1
R01$693,558 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Andre Elias Nel$21,296,649
- Donald P Tashkin$15,930,292
- Jesus Antonio Araujo$8,247,283
- Michael D Roth$8,922,704
- Dinesh Khanna$4,798,098
Others in their field
Other Emerging Leaders on “Mycophenolate”
- Marlena Habal · Columbia University Health Sciences$5,158,955
- Elizabeth Ann Sugar · Johns Hopkins University$4,502,229
- Sunil Kannanganat Sidharthan · Astero Erado Inc$3,497,467
- Daniel R Wahl · University Of Michigan At Ann Arbor$3,484,771
- Bret David Wallace · Symberix, Inc.$1,968,927
- James Craig Hartman · Mdi Therapeutics, Inc.$1,493,970
Research focus
MycophenolateResponseHigh Resolution Computed TomographyMortalityPredicting ResponsePulmonary FunctionDisease ProgressionGlassInterstitial Lung DiseasesMeasurementPatient-Focused OutcomesPatient SubsetsPrediction Of Response To TherapyPulmonary FibrosisBiologicalCause Of DeathFibrosisFutureBiological MarkersInnovationCohortLungBloodSystemic Scleroderma
Grant awards (6)
Functional Response Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease$693,558
R01 · FY2025 · HL · contact PI
Identifying predictors of treatment response in systemic sclerosis-related interstitial lung disease$182,066
K23 · FY2024 · HL · contact PI
Identifying predictors of treatment response in systemic sclerosis-related interstitial lung disease$182,066
K23 · FY2023 · HL · contact PI
Identifying predictors of treatment response in systemic sclerosis-related interstitial lung disease$182,066
K23 · FY2022 · HL · contact PI
Identifying predictors of treatment response in systemic sclerosis-related interstitial lung disease$182,066
K23 · FY2021 · HL · contact PI
Identifying predictors of treatment response in systemic sclerosis-related interstitial lung disease$182,066
K23 · FY2020 · HL · contact PI